3,3'-亚戊烯基-4-丁内酰胺
2-Azaspiro[4.5]decan-3-one;3,3-Pentamethylene-4-butyrolactam;2-Azaspiro-[4,5]-Decan-3-One;4,4-Pentamethylene-2-pyrrolidone;2-AZASPIRO-(4,5)-DECAN-3-ONE;3,3-Pentenylene-4-butyrolactam;4,4-Pentamethylene-2-pyrrolidinone;Gabapentin Related Compound A;Gabapentin-lactam;3,3-Pentamethylene-4-butyrolac;forgabapentine;GABA-pentinlactam;Pentamethylene pyrrolidinone;Gabapentin Impurity A;3-Azaspiro[4.5]decan-2-one;Gabapentin lactam;2-AZASPIRO(4,5)DECAN-3-ONE;2-Aza-spiro[4.5]decan-3-one;JAWPQJDOQPSNIQ-UHFFFAOYSA-N;beta,beta-Pentamethylen-gamma-butyrolactam [German];0IP6953295;2-Azaspiro(4.5)decan-3-one;PubChem20713;PubChem15198;beta,beta-Pentameth;2-azaspiro[4.5]decan-3-one;.beta.,.beta.-Pentamethylen-.gamma.-butyrolactam;NS00011447;8-aza-spiro(5,4)decan-9-on;MFCD00177938;Gabapentin-lactam 100 microg/mL in Acetonitrile;BRN 0119500;EC 451-630-1;EN300-94425;64744-50-9;2-Aza-spiro[4,5]decan-3-one;CHEMBL3115477;KS-5267;4,4-Pentamethylene-2-pyrrolidinone, 96%;P1695;DTXSID40215070;CS-0096868;1-(Aminomethyl)cyclohexaneacetic acid lactam;GABAPENTIN IMPURITY A [EP IMPURITY];2-Pyrrolidone, 4,4-pentamethylene-;SCHEMBL483007;AC1536;2-PYRROLIDONE,4,4-PENTAMETHYLENE;Gabapentin impurity A, European Pharmacopoeia (EP) Reference Standard;5-21-07-00071 (Beilstein Handbook Reference);8-aza-spiro[5,4]decan-9-on;Q27236831;FT-0640970;beta, beta-pentamethylen-gamma-butyrolactam;SY006466;Z1255399250;InChI=1/C9H15NO/c11-8-6-9(7-10-8)4-2-1-3-5-9/h1-7H2,(H,10,11;AKOS005169332;AC-8435;GABAPENTIN LACTAM [NFLIS-DRUG];Q-200416;2-bromo-2-(4-methoxy-phenyl-hydrazono)-aceticacidethylester;UNII-0IP6953295;2-Azaspiro[4.5]decan-3-one (3,3-Pentamethylene-4-butyrolactam);CHEBI:182289;beta,beta-Pentamethylen-gamma-butyrolactam